×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
DBVT – dbv technologies s.a. - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
DBVT
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/7
02:07 am
dbvt
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/30
02:02 am
dbvt
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/27
10:30 pm
dbvt
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
High
Report
DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
3/24
02:30 am
dbvt
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
Medium
Report
DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
3/22
02:04 am
dbvt
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/14
02:00 am
dbvt
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/10
07:38 am
dbvt
Versatope Adds New Board Members [Yahoo! Finance]
Medium
Report
Versatope Adds New Board Members [Yahoo! Finance]
3/6
02:09 am
dbvt
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
DBV Technologies S.A. (NASDAQ: DBVT) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
11/6/2024
04:30 pm
DBVT
dbv technologies s.a. - american depositary shares
BEAT
Report
-4.0%
dbv technologies s.a. - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
1/10
10:18 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
18.9%
1/10
10:18 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
18.9%
1/10
10:09 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
20.3%
1/10
10:09 am
Reiterates
Market Outperform
Market Outperform
JMP Securities
High
Report
20.3%
Date
Time
Symbol
Headline
Impact
4/7
04:51 pm
dbvt
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
Low
Report
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: Bpifrance Participations SA
4/7
04:01 pm
dbvt
Form 3 DBV Technologies S.A. For: Mar 27 Filed by: Bpifrance SA
Low
Report
Form 3 DBV Technologies S.A. For: Mar 27 Filed by: Bpifrance SA
3/31
07:35 pm
dbvt
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: BAKER BROS. ADVISORS LP
Medium
Report
Form SCHEDULE 13D/A DBV Technologies S.A. Filed by: BAKER BROS. ADVISORS LP
3/31
06:56 pm
dbvt
Form 4 DBV Technologies S.A. For: Mar 27 Filed by: 667, L.P.
Medium
Report
Form 4 DBV Technologies S.A. For: Mar 27 Filed by: 667, L.P.
3/31
04:31 pm
dbvt
Form NT 10-K DBV Technologies S.A. For: Dec 31
Medium
Report
Form NT 10-K DBV Technologies S.A. For: Dec 31
3/31
04:02 pm
dbvt
Form 8-K DBV Technologies S.A. For: Mar 27
Medium
Report
Form 8-K DBV Technologies S.A. For: Mar 27
3/24
07:01 am
dbvt
Form 8-K DBV Technologies S.A. For: Mar 24
Medium
Report
Form 8-K DBV Technologies S.A. For: Mar 24
2/14
04:27 pm
dbvt
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: BRAIDWELL LP
High
Report
Form SCHEDULE 13G/A DBV Technologies S.A. Filed by: BRAIDWELL LP
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/18
DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Bryan, Garnier & Co from a "buy" rating to a "neutral" rating.
27.9%
3/17 Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 25.8%
1/8 DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy 14.8%
4/21 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 14.1%
4/14 Form 6-K DBV Technologies S.A. For: Apr 13 13.6%
4/7 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.25 price target on the stock. 10.6%
7/3 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 10.2%
8/7 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy 9.5%
2/26 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.7%
4/15 Monthly information regarding the total number of voting rights and total number of shares of the Company 5.8%
3/17 Monthly information regarding the total number of voting rights and total number of shares of the Company as of February 29, 2020 and March 4, 2020 25.8%
1/8 DBV Technologies Reports Positive Three-Year, Long-Term Data from the PEOPLE Phase III Open-Label Extension Study of Viaskin Peanut in Children with Peanut Allergy 14.8%
4/21 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 14.1%
4/14 Form 6-K DBV Technologies S.A. For: Apr 13 13.6%
4/7 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.25 price target on the stock. 10.6%
7/3 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 10.2%
8/7 DBV Technologies Submits Biologics License Application to U.S. Food and Drug Administration for Viaskin Peanut for the Treatment of Peanut Allergy 9.5%
2/26 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. 7.7%
4/15 Monthly information regarding the total number of voting rights and total number of shares of the Company 5.8%
TOP News Decliners
3/10
DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $9.25 price target on the stock.
-14.2%
1/29 Form 6-K DBV Technologies S.A. For: Jan 29 -13.2%
3/12 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -11.7%
3/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. -11.6%
12/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock. -8.7%
2/4 Form 6-K DBV Technologies S.A. For: Feb 04 -8.6%
3/5 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $18.00 price target on the stock. -8.5%
1/9 Form 6-K DBV Technologies S.A. For: Jan 08 -8.4%
10/9 DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares -8.2%
4/14 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock. -8.2%
1/29 Form 6-K DBV Technologies S.A. For: Jan 29 -13.2%
3/12 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -11.7%
3/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was downgraded by analysts at Kepler Capital Markets from a "buy" rating to a "hold" rating. -11.6%
12/20 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock. -8.7%
2/4 Form 6-K DBV Technologies S.A. For: Feb 04 -8.6%
3/5 DBV TECHNOLOGIE/S (NASDAQ: DBVT) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $18.00 price target on the stock. -8.5%
1/9 Form 6-K DBV Technologies S.A. For: Jan 08 -8.4%
10/9 DBV Technologies Announces Pricing of $125 million (€114 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares -8.2%
4/14 DBV TECHNOLOGIE/S (NASDAQ: DBVT) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $4.75 price target on the stock. -8.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: